Autonomix Medical, Inc.

Name: Autonomix Medical, Inc. standardized financial statements, quarterly
Creator: Listed

AMIXNasdaqCIK 1617867HealthcareFiscal year ends Mar 31

Share this page

Link

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$0, Q1 FY2027

Operating income−$2.8m, Q1 FY2027

Net income−$2.7m, Q1 FY2027

Autonomix Medical, Inc., income statement, quarterly
Line item	Unit	period not labelled2023-09-30	Q3 FY20242023-12-31	Q4 FY20242024-03-31	Q1 FY20252024-06-30	Q2 FY20252024-09-30	Q3 FY20252024-12-31	Q4 FY20252025-03-31	Q1 FY20262025-06-30	Q2 FY20262025-09-30	Q3 FY20262025-12-31	Q4 FY20262026-03-31	Q1 FY20272026-06-30
Revenue	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Research and development	$m	0.5	0.7	0.7	1.0	1.2	1.0	1.6	1.6	2.4	1.7	1.5	1.5
Operating income	$m	(5.8)	(2.9)	(2.4)	(2.8)	(2.8)	(2.7)	(3.3)	(3.4)	(7.5)	(3.3)	(2.7)	(2.8)
Interest expense	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	not reported
Income tax	$m	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Net income	$m	(6.0)	(3.1)	(15.4)	(2.7)	(2.8)	(2.7)	(11.4)	(3.3)	(7.5)	(3.3)	(2.7)	(2.7)
Diluted EPS	$ per share	not reported	(0.23)	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Basic EPS	$ per share	(8.78)	(3.07)	not reported	(2.20)	(2.27)	(1.46)	not reported	(22.69)	(1.38)	(0.36)	not reported	(5.02)

Balance sheet

Cash and equivalents$3.5m, Q1 FY2027

Long-term debt$1.5m, Q3 FY2024

Shareholders' equity$3.2m, Q1 FY2027

Autonomix Medical, Inc., balance sheet, quarterly
Line item	Unit	period not labelled2023-09-30	Q3 FY20242023-12-31	FY20242024-03-31	Q1 FY20252024-06-30	Q2 FY20252024-09-30	Q3 FY20252024-12-31	FY20252025-03-31	Q1 FY20262025-06-30	Q2 FY20262025-09-30	Q3 FY20262025-12-31	FY20262026-03-31	Q1 FY20272026-06-30
Cash and equivalents	$m	not reported	1.2	8.6	6.8	5.2	11.8	9.1	8.6	7.5	9.9	7.0	3.5
Current assets	$m	not reported	1.7	9.4	7.1	5.4	11.9	9.6	9.0	7.9	10.2	7.6	4.0
Total assets	$m	not reported	1.8	9.4	7.1	5.4	12.0	9.8	9.0	7.9	10.2	7.6	4.0
Current liabilities	$m	not reported	1.0	0.8	0.8	1.3	2.2	1.7	2.0	1.5	1.7	1.7	0.8
Total liabilities	$m	not reported	7.4	1.8	1.8	2.3	2.2	1.7	2.0	1.5	1.7	1.7	0.8
Long-term debt	$m	not reported	1.5	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported	not reported
Short-term borrowings	$m	not reported	not reported	0.0	not reported	not reported	1.1	not reported	not reported	not reported	not reported	not reported	not reported
Shareholders' equity	$m	(2.9)	(5.6)	7.6	5.3	3.0	9.7	8.1	7.0	6.4	8.6	5.9	3.2

Cash flow

Operating cash flow−$3.5m, Q1 FY2027

Capital expenditure$3.0k, Q4 FY2026

Autonomix Medical, Inc., cash flow, quarterly
Line item	Unit	period not labelled2023-09-30	Q3 FY20242023-12-31	Q4 FY20242024-03-31	Q1 FY20252024-06-30	Q2 FY20252024-09-30	Q3 FY20252024-12-31	Q4 FY20252025-03-31	Q1 FY20262025-06-30	Q2 FY20262025-09-30	Q3 FY20262025-12-31	Q4 FY20262026-03-31	Q1 FY20272026-06-30
Operating cash flow	$k	(1,144)	(2,556)	(6,648)	(1,852)	(1,596)	(2,301)	(8,258)	(2,604)	(3,817)	(2,969)	(2,892)	(3,544)
Capital expenditure	$k	0.0	16.0	19.0	5.0	0.0	5.0	14.0	0.0	0.0	7.0	3.0	not reported

Diluted shares (weighted)13.80m, Q3 FY2024

Autonomix Medical, Inc., shares, quarterly
Line item	Unit	period not labelled2022-12-31	Q3 FY20242023-12-31
Diluted shares (weighted)	m shares	12.0	13.8

Shares outstanding: 971,043 at Aug 6, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:44 ET. Listed shows no prices and gives no investment advice.